These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6320556)

  • 1. [In vitro study of macrophage barrier function in mice vaccinated against tick-borne encephalitis and infection with flaviviruses of varying virulence].
    Karaseva PS; Khotlubeĭ LI; El'bert LB; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Dec; (12):57-60. PubMed ID: 6320556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectors of in vivo delayed hypersensitivity in experimental flavivirus infections and vaccination against tick-borne encephalitis in mice].
    Lipovka VA; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):83-8. PubMed ID: 6098109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of macrophages in the pathogenesis of experimental tick-borne encephalitis in mice.
    Khozinsky VV; Semenov BF; Gresíková M; Chunikhin SP; Sekeyová M; Kozuch O
    Acta Virol; 1985 May; 29(3):194-202. PubMed ID: 2864820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A live vaccine against tick-borne encephalitis: the principles of selecting the vaccinal strains].
    Kamalov II; Sokolova ED; Il'enko VI; Rozhkova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):70-6. PubMed ID: 8067096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
    Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
    Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.
    Klockmann U; Bock HL; Kwasny H; Praus M; Cihlová V; Tomková E; Krivanec K
    Vaccine; 1991 Jan; 9(1):42-6. PubMed ID: 2008800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional activity of specific antibodies in patients vaccinated against tick-borne encephalitis in relation to different virus strains].
    Leonova GN; Pavlenko EV
    Vopr Virusol; 2010; 55(3):33-7. PubMed ID: 20608079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the response of mice with temporary immunodepression to the administration of live or inactivated vaccine against tick-borne encephalitis].
    Vargin VV; Semenov BF
    Vopr Virusol; 1979; (1):52-7. PubMed ID: 217179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.